RxPress Issues
November-December 2011 edition
- Status Update on the National Cardiovascular Prevention Guidelines
- Drosperinone-Containing Oral Contraceptives and Venous Thromboembolism Risk
- P&T Committee Formulary Action
September-October 2011 edition
- New Oral Anticoagulant (Rivaroxaban [Xarelto])
- New Antiplatelet (Ticagrelor [Brilinta])
- Update on Dabigatran (Pradaxa) Safety and Use at UIMCC
- What Methods are Available for Reversal of Dabigatran and Rivaroxaban?
- P&T Committee Formulary Action
July-August 2011 edition
- Drug Safety Concerns in Pediatric Patients
- Safety data with pioglitazone and bladder cancer
- New FDA Dosing Recommendations for Erythropoiesis-Stimulating Agents
May-June 2011 edition
- Use of PPIs in noncritically ill patients—risk of gastrointestinal bleeding
- Update on use of vitamin D—2011 guidelines from the Endocrine Society
- Intravenous acetaminophen—use and efficacy in pediatric patients
- P&T Committee Formulary Action
March-April 2011 edition
- Food and Drug Administration 2010-2011 Drug Safety News
- Drug Shortages: Impact, Etiology, and Effective Management
- P&T Committee Formulary Action
January-February 2011 edition
- New MRSA Treatment Guidelines from IDSA
- What’s New in Atrial Fibrillation?
- FDA Limits for Acetaminophen-containing Products
- P&T Committee Formulary Action
Archives
